Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK

Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK

Introduction:: Overactive bladder (OAB) affects 27% of women in the UK with an adverse impact on quality of life. Medical treatment with anticholinergics has a high discontinuation rate due to side effects. OnabotulinumtoxinA (BOTOX ®) is an established treatment for refractory OAB, although there a...

Full description

Bibliographic Details
Main Authors: R. Mohamed-Ahmed, C. Tomlinson, A. Taithongchai, A. Rantell, G. Araklitis, D. Robinson, L. Cardozo
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Continence
Subjects:
Botox
Overactive bladder
Detrusor overactivity
Recurrent UTIs
Online Access:http://www.sciencedirect.com/science/article/pii/S2772973723009244

Similar Items

Similar Items